Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mom's voice or scent may ease Baby's pain during blood test

NCT ID NCT07651592

Symptom relief Sponsor: Kilis 7 Aralik University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a mother's voice, touch, or scent can reduce pain and stress in newborns during a routine heel prick for blood sampling. 120 healthy full-term babies will be randomly assigned to hear their mother's voice, feel her touch, smell her breast milk, or receive standard care. Researchers will measure pain and stress using behavioral and physical signs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
maternal voice, touch, or scent
What this could lead to
If effective, this could provide simple, low-cost ways to comfort newborns during routine medical procedures.
What could go wrong
This is a small, early-stage trial with 120 babies. Results may not apply to all newborns or procedures, and the effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Term newborns born between 37 and 42 weeks of gestation * Newborns without respiratory, cardiac, metabolic, neurological, or infectious diseases * Newborns not requiring oxygen therapy, phototherapy, or intravenous treatment * Newborns scheduled to undergo a routine heel lance procedure (metabolic screening or blood sampling) * Mothers willing to participate in the study * Written informed consent provided by the parent or legal guardian * Normal vital signs before the procedure (heart rate, respiratory rate, and oxygen saturation within normal limits) Exclusion Criteria: * Preterm (\<37 weeks) or post-term (\>42 weeks) newborns * Presence of congenital anomalies or neurological disorders * Requirement for oxygen therapy, phototherapy, or intravenous treatment * Respiratory, cardiac, metabolic, neurological, or infectious disease * Abnormal vital signs before the procedure * Parent or legal guardian refusal to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neonatal pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neonatal pain Stress, psychological

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kilis Alaeddin Yavaşça State Hospital

    Kilis, 79000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.